![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 29, 30871-30879, July 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710
The alveolar epithelium is lined by surfactant, a lipoprotein complex that both reduces surface tension and mediates several innate immune functions including bacterial aggregation, alteration of alveolar macrophage function, and regulation of bacterial clearance. Surfactant protein-D (SP-D) participates in several of these immune functions, and specifically it enhances the clearance of the pulmonary pathogen Pseudomonas aeruginosa, a common cause of morbidity and mortality in cystic fibrosis (CF) patients. P. aeruginosa secretes a variety of virulence factors including elastase, a zinc-metalloprotease, which degrades both SP-A and SP-D. Here we show that SP-D is cleaved by elastase to produce a stable 35-kDa fragment in a time-, temperature-, and dose-dependent manner. Degradation is inhibited by divalent metal cations, a metal chelator, and the elastase inhibitor, phosphoramidon. Sequencing the SP-D degradation products localized the major cleavage sites to the C-terminal lectin domain. The SP-D fragment fails to bind or aggregate bacteria that are aggregated by intact SP-D. SP-D fragment is observed when normal rat bronchoalveolar lavage (BAL) is treated with Pseudomonas aeruginosa elastase, and SP-D fragments are present in the BAL of CF lung allograft patients. These data show that degradation of SP-D occurs in the BAL environment and that degradation eliminates many normal immune functions of SP-D.
Received for publication, January 23, 2004 , and in revised form, April 30, 2004.
* This work was supported by National Institutes of Health Grant HL-51134. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence and reprint requests should be addressed: Dept. of Cell Biology, Box 3709, Durham, NC 27710. Tel.: 919-684-8040; Fax: 919-684-8106; E-mail: j.wright{at}cellbio.duke.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Griese, M. Kappler, A. Gaggar, and D. Hartl Inhibition of airway proteases in cystic fibrosis lung disease Eur. Respir. J., September 1, 2008; 32(3): 783 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cooley, B. McDonald, F. J. Accurso, E. C. Crouch, and E. Remold-O'Donnell Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease J. Leukoc. Biol., April 1, 2008; 83(4): 946 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abusriwil and R. A. Stockley The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage Proceedings of the ATS, December 1, 2007; 4(8): 611 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Leduc, N. Beaufort, S. de Bentzmann, J.-C. Rousselle, A. Namane, M. Chignard, and D. Pidard The Pseudomonas aeruginosa LasB Metalloproteinase Regulates the Human Urokinase-Type Plasminogen Activator Receptor through Domain-Specific Endoproteolysis Infect. Immun., August 1, 2007; 75(8): 3848 - 3858. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Grubor, D. K. Meyerholz, and M. R. Ackermann Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet. Pathol., September 1, 2006; 43(5): 595 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Starner and P. B. McCray Jr. Pathogenesis of Early Lung Disease in Cystic Fibrosis: A Window of Opportunity To Eradicate Bacteria Ann Intern Med, December 6, 2005; 143(11): 816 - 822. [Full Text] [PDF] |
||||
![]() |
A. P. Moran, W. Khamri, M. M. Walker, and M. R. Thursz Role of surfactant protein D (SP-D) in innate immunity in the gastric mucosa: evidence of interaction with Helicobacter pylori lipopolysaccharide Innate Immunity, December 1, 2005; 11(6): 357 - 362. [Abstract] [PDF] |
||||
![]() |
A. B. Fisher, C. Dodia, S. I. Feinstein, and Y.-S. Ho Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2 J. Lipid Res., June 1, 2005; 46(6): 1248 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ni, D. J. Evans, S. Hawgood, E. M. Anders, R. A. Sack, and S. M. J. Fleiszig Surfactant Protein D Is Present in Human Tear Fluid and the Cornea and Inhibits Epithelial Cell Invasion by Pseudomonas aeruginosa Infect. Immun., April 1, 2005; 73(4): 2147 - 2156. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Malloy, R. A. W. Veldhuizen, B. A. Thibodeaux, R. J. O'Callaghan, and J. R. Wright Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L409 - L418. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |